| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 34 | 2022 | 384 | 6.780 |
Why?
|
| Zebrafish | 95 | 2023 | 3037 | 6.280 |
Why?
|
| Neuroblastoma | 38 | 2023 | 1266 | 4.350 |
Why?
|
| Zebrafish Proteins | 30 | 2020 | 1019 | 4.220 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 21 | 2017 | 167 | 3.120 |
Why?
|
| Neurofibromin 1 | 6 | 2021 | 190 | 2.500 |
Why?
|
| Animals, Genetically Modified | 41 | 2020 | 1563 | 2.260 |
Why?
|
| Gene Expression Regulation, Leukemic | 22 | 2021 | 656 | 2.110 |
Why?
|
| Cell Transformation, Neoplastic | 23 | 2024 | 2846 | 2.020 |
Why?
|
| Proto-Oncogene Proteins | 31 | 2020 | 4526 | 1.960 |
Why?
|
| Apoptosis | 54 | 2021 | 9516 | 1.750 |
Why?
|
| Proto-Oncogene Proteins c-myc | 14 | 2018 | 998 | 1.730 |
Why?
|
| Tumor Suppressor Protein p53 | 15 | 2022 | 2952 | 1.660 |
Why?
|
| TYK2 Kinase | 4 | 2018 | 38 | 1.650 |
Why?
|
| Hematopoiesis | 21 | 2017 | 2058 | 1.640 |
Why?
|
| DNA-Binding Proteins | 40 | 2023 | 9614 | 1.580 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 14 | 2023 | 1141 | 1.520 |
Why?
|
| Embryo, Nonmammalian | 14 | 2019 | 911 | 1.460 |
Why?
|
| Enhancer Elements, Genetic | 10 | 2020 | 1368 | 1.400 |
Why?
|
| Karyopherins | 3 | 2016 | 134 | 1.360 |
Why?
|
| Transcription Factors | 37 | 2023 | 12166 | 1.360 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 12 | 2020 | 1558 | 1.340 |
Why?
|
| Gene Expression Regulation, Neoplastic | 31 | 2021 | 8634 | 1.320 |
Why?
|
| Topoisomerase I Inhibitors | 2 | 2020 | 70 | 1.320 |
Why?
|
| Leukemia, Myeloid, Acute | 11 | 2023 | 3620 | 1.270 |
Why?
|
| Receptor, Notch1 | 13 | 2014 | 520 | 1.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 10 | 2020 | 2460 | 1.270 |
Why?
|
| Nerve Sheath Neoplasms | 3 | 2019 | 170 | 1.260 |
Why?
|
| Dioxygenases | 3 | 2023 | 351 | 1.250 |
Why?
|
| Oncogene Proteins | 15 | 2014 | 718 | 1.240 |
Why?
|
| Hematopoietic Stem Cells | 17 | 2023 | 3407 | 1.240 |
Why?
|
| Trans-Activators | 11 | 2020 | 2856 | 1.170 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 12 | 2021 | 1409 | 1.110 |
Why?
|
| Nuclear Proteins | 25 | 2018 | 5800 | 1.110 |
Why?
|
| Leukemia | 10 | 2020 | 1526 | 1.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2016 | 861 | 1.030 |
Why?
|
| Oncogenes | 12 | 2022 | 1235 | 1.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 5 | 2017 | 82 | 0.990 |
Why?
|
| Animals | 149 | 2023 | 169337 | 0.980 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2021 | 1119 | 0.970 |
Why?
|
| Myelodysplastic Syndromes | 8 | 2014 | 1399 | 0.970 |
Why?
|
| Cell Cycle Proteins | 13 | 2020 | 3458 | 0.960 |
Why?
|
| Repressor Proteins | 6 | 2021 | 2986 | 0.950 |
Why?
|
| Cell Line, Tumor | 45 | 2022 | 17135 | 0.900 |
Why?
|
| TOR Serine-Threonine Kinases | 7 | 2020 | 2066 | 0.900 |
Why?
|
| Mutation | 47 | 2019 | 30228 | 0.900 |
Why?
|
| Neurofibromatosis 1 | 4 | 2019 | 561 | 0.860 |
Why?
|
| Cell Survival | 27 | 2021 | 5792 | 0.860 |
Why?
|
| Haploinsufficiency | 4 | 2021 | 336 | 0.860 |
Why?
|
| Bone Marrow Neoplasms | 3 | 2021 | 101 | 0.850 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2016 | 432 | 0.840 |
Why?
|
| Genes, Neurofibromatosis 1 | 3 | 2012 | 74 | 0.840 |
Why?
|
| Embryonic Development | 6 | 2012 | 722 | 0.830 |
Why?
|
| Ganglioneuroma | 2 | 2020 | 53 | 0.790 |
Why?
|
| Signal Transduction | 40 | 2024 | 23631 | 0.780 |
Why?
|
| Chromosome Deletion | 7 | 2021 | 1390 | 0.770 |
Why?
|
| Neoplasm Proteins | 11 | 2019 | 3610 | 0.760 |
Why?
|
| Disease Models, Animal | 23 | 2021 | 18362 | 0.740 |
Why?
|
| Protein Phosphatase 2 | 3 | 2020 | 231 | 0.730 |
Why?
|
| Genes, p53 | 6 | 2016 | 716 | 0.730 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 11 | 2012 | 3794 | 0.710 |
Why?
|
| Neurofibrosarcoma | 1 | 2020 | 27 | 0.710 |
Why?
|
| Rhabdoid Tumor | 1 | 2022 | 211 | 0.710 |
Why?
|
| Translocation, Genetic | 12 | 2018 | 1395 | 0.700 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2020 | 108 | 0.680 |
Why?
|
| Tumor Suppressor Proteins | 10 | 2012 | 2812 | 0.680 |
Why?
|
| Chromosome Aberrations | 8 | 2013 | 1780 | 0.670 |
Why?
|
| Genes, myc | 8 | 2011 | 391 | 0.670 |
Why?
|
| Thiophenes | 2 | 2021 | 569 | 0.670 |
Why?
|
| Sarcoma, Experimental | 1 | 2019 | 117 | 0.650 |
Why?
|
| Cell Cycle | 13 | 2020 | 2938 | 0.640 |
Why?
|
| F-Box Proteins | 2 | 2013 | 201 | 0.640 |
Why?
|
| Protein Kinase Inhibitors | 11 | 2023 | 5708 | 0.640 |
Why?
|
| Myeloid Cells | 6 | 2011 | 832 | 0.630 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 9 | 2021 | 153 | 0.620 |
Why?
|
| Transcriptional Activation | 9 | 2021 | 1748 | 0.610 |
Why?
|
| Base Sequence | 23 | 2019 | 12422 | 0.600 |
Why?
|
| Drug Synergism | 2 | 2021 | 1762 | 0.590 |
Why?
|
| Gene Deletion | 5 | 2011 | 2673 | 0.590 |
Why?
|
| Myeloid Progenitor Cells | 4 | 2006 | 112 | 0.560 |
Why?
|
| Hydrazines | 2 | 2016 | 223 | 0.560 |
Why?
|
| Xenograft Model Antitumor Assays | 10 | 2021 | 3617 | 0.560 |
Why?
|
| Molecular Sequence Data | 32 | 2014 | 17626 | 0.550 |
Why?
|
| Genes, Tumor Suppressor | 5 | 2014 | 1064 | 0.540 |
Why?
|
| Ribosomal Proteins | 4 | 2014 | 370 | 0.530 |
Why?
|
| Gene Silencing | 5 | 2020 | 1503 | 0.530 |
Why?
|
| Oncogene Proteins, Fusion | 11 | 2011 | 1614 | 0.520 |
Why?
|
| STAT1 Transcription Factor | 2 | 2018 | 343 | 0.520 |
Why?
|
| Sulfonamides | 4 | 2021 | 1980 | 0.520 |
Why?
|
| Homeodomain Proteins | 11 | 2011 | 2429 | 0.520 |
Why?
|
| Antineoplastic Agents | 12 | 2020 | 13697 | 0.510 |
Why?
|
| T-Lymphocytes | 11 | 2018 | 10267 | 0.510 |
Why?
|
| Chromosomes, Human, Pair 5 | 5 | 2014 | 387 | 0.500 |
Why?
|
| Pyrimidines | 5 | 2021 | 3048 | 0.500 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 3 | 2024 | 168 | 0.500 |
Why?
|
| Peripheral Nerves | 1 | 2019 | 492 | 0.500 |
Why?
|
| Resorcinols | 1 | 2015 | 41 | 0.500 |
Why?
|
| RNA-Binding Proteins | 3 | 2020 | 1883 | 0.490 |
Why?
|
| Cell Proliferation | 21 | 2021 | 10478 | 0.490 |
Why?
|
| Receptors, Laminin | 1 | 2014 | 26 | 0.480 |
Why?
|
| Mice | 62 | 2023 | 82017 | 0.480 |
Why?
|
| Humans | 182 | 2024 | 768393 | 0.480 |
Why?
|
| Green Fluorescent Proteins | 12 | 2017 | 2069 | 0.480 |
Why?
|
| Zinc Fingers | 4 | 2011 | 577 | 0.470 |
Why?
|
| Gene Amplification | 12 | 2018 | 1090 | 0.470 |
Why?
|
| In Situ Hybridization | 14 | 2014 | 1905 | 0.470 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2010 | 474 | 0.460 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 368 | 0.460 |
Why?
|
| Leukemia, T-Cell | 5 | 2013 | 101 | 0.460 |
Why?
|
| Protein-Tyrosine Kinases | 9 | 2018 | 2433 | 0.460 |
Why?
|
| DNA, Intergenic | 1 | 2014 | 108 | 0.460 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 5 | 2012 | 1628 | 0.460 |
Why?
|
| Sarcoma | 2 | 2022 | 1807 | 0.460 |
Why?
|
| Gene Expression Profiling | 21 | 2021 | 9510 | 0.450 |
Why?
|
| Semen Preservation | 2 | 2004 | 35 | 0.450 |
Why?
|
| Neoplastic Stem Cells | 4 | 2015 | 1356 | 0.450 |
Why?
|
| Isoxazoles | 1 | 2015 | 233 | 0.440 |
Why?
|
| INDEL Mutation | 1 | 2014 | 267 | 0.440 |
Why?
|
| Point Mutation | 3 | 2017 | 1594 | 0.440 |
Why?
|
| Adrenergic Agents | 3 | 2023 | 73 | 0.430 |
Why?
|
| Enzyme Inhibitors | 10 | 2016 | 3722 | 0.430 |
Why?
|
| Triazoles | 2 | 2016 | 904 | 0.430 |
Why?
|
| Acetylcysteine | 1 | 2014 | 262 | 0.430 |
Why?
|
| Nuclear Export Signals | 1 | 2012 | 8 | 0.420 |
Why?
|
| Gene Expression Regulation, Developmental | 17 | 2011 | 3612 | 0.410 |
Why?
|
| ran GTP-Binding Protein | 1 | 2012 | 53 | 0.410 |
Why?
|
| Cell Movement | 12 | 2020 | 5215 | 0.410 |
Why?
|
| Erythropoiesis | 4 | 2019 | 693 | 0.410 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2015 | 423 | 0.410 |
Why?
|
| Proto-Oncogenes | 2 | 2003 | 322 | 0.400 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 13 | 2012 | 4588 | 0.400 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2014 | 2884 | 0.400 |
Why?
|
| Alleles | 14 | 2022 | 6892 | 0.390 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2016 | 230 | 0.390 |
Why?
|
| Apoptosis Regulatory Proteins | 7 | 2015 | 1151 | 0.390 |
Why?
|
| Autocrine Communication | 1 | 2012 | 168 | 0.380 |
Why?
|
| Myeloproliferative Disorders | 3 | 2013 | 613 | 0.380 |
Why?
|
| Epidermis | 2 | 2011 | 539 | 0.370 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2011 | 16 | 0.370 |
Why?
|
| Gene Expression | 9 | 2017 | 7598 | 0.370 |
Why?
|
| Neurilemmoma | 1 | 2016 | 524 | 0.370 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2013 | 1901 | 0.370 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2017 | 16028 | 0.370 |
Why?
|
| Receptors, Notch | 5 | 2014 | 751 | 0.370 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 2010 | 16 | 0.360 |
Why?
|
| Sequence Deletion | 6 | 2010 | 1497 | 0.360 |
Why?
|
| MicroRNAs | 5 | 2020 | 3804 | 0.350 |
Why?
|
| Up-Regulation | 8 | 2019 | 4142 | 0.350 |
Why?
|
| Blotting, Western | 9 | 2012 | 5037 | 0.350 |
Why?
|
| Oligodendroglia | 2 | 2012 | 540 | 0.340 |
Why?
|
| Mutagenesis | 2 | 2011 | 1229 | 0.340 |
Why?
|
| Caspase 2 | 2 | 2012 | 26 | 0.340 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2010 | 123 | 0.340 |
Why?
|
| Transcription, Genetic | 12 | 2020 | 7599 | 0.330 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2010 | 85 | 0.330 |
Why?
|
| Codon, Terminator | 1 | 2010 | 125 | 0.330 |
Why?
|
| Karyotyping | 5 | 2014 | 1173 | 0.330 |
Why?
|
| Polymerase Chain Reaction | 6 | 2011 | 6085 | 0.330 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2016 | 1766 | 0.330 |
Why?
|
| Uniparental Disomy | 1 | 2009 | 46 | 0.320 |
Why?
|
| Cell Differentiation | 13 | 2019 | 11668 | 0.320 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 7 | 2023 | 11854 | 0.320 |
Why?
|
| Transgenes | 7 | 2017 | 1015 | 0.320 |
Why?
|
| Gene Transfer Techniques | 3 | 2011 | 1209 | 0.310 |
Why?
|
| Liposarcoma | 1 | 2011 | 289 | 0.310 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 891 | 0.310 |
Why?
|
| Loss of Heterozygosity | 7 | 2013 | 663 | 0.310 |
Why?
|
| Lymphoma, T-Cell | 3 | 2007 | 303 | 0.310 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 1753 | 0.310 |
Why?
|
| Neural Crest | 4 | 2010 | 279 | 0.310 |
Why?
|
| DNA Damage | 7 | 2014 | 2458 | 0.310 |
Why?
|
| Cryopreservation | 2 | 2004 | 733 | 0.310 |
Why?
|
| Promoter Regions, Genetic | 14 | 2023 | 5801 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2012 | 567 | 0.300 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 384 | 0.300 |
Why?
|
| Mice, SCID | 6 | 2021 | 2632 | 0.300 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2022 | 792 | 0.300 |
Why?
|
| Amino Acid Sequence | 19 | 2012 | 13423 | 0.300 |
Why?
|
| Myelopoiesis | 2 | 2005 | 135 | 0.300 |
Why?
|
| Mice, Inbred NOD | 5 | 2017 | 1839 | 0.300 |
Why?
|
| Mutagenesis, Insertional | 4 | 2018 | 662 | 0.290 |
Why?
|
| Models, Animal | 5 | 2006 | 2124 | 0.290 |
Why?
|
| Phenothiazines | 2 | 2020 | 61 | 0.290 |
Why?
|
| Carcinogens | 2 | 2007 | 455 | 0.290 |
Why?
|
| Melanoma | 5 | 2021 | 5705 | 0.290 |
Why?
|
| Blood Vessels | 2 | 2010 | 1110 | 0.280 |
Why?
|
| Gene Duplication | 2 | 2007 | 315 | 0.280 |
Why?
|
| Amyloid Precursor Protein Secretases | 6 | 2009 | 614 | 0.280 |
Why?
|
| Alu Elements | 1 | 2007 | 116 | 0.280 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2023 | 18048 | 0.280 |
Why?
|
| Gamma Rays | 6 | 2010 | 319 | 0.280 |
Why?
|
| Protein Binding | 7 | 2020 | 9343 | 0.280 |
Why?
|
| Thymus Neoplasms | 2 | 2010 | 277 | 0.280 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2011 | 3731 | 0.280 |
Why?
|
| alpha Catenin | 1 | 2006 | 37 | 0.280 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 1133 | 0.270 |
Why?
|
| Neoplasm Transplantation | 7 | 2021 | 2017 | 0.270 |
Why?
|
| Leukemia, Myeloid | 4 | 2006 | 693 | 0.270 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2007 | 130 | 0.270 |
Why?
|
| Lymphocyte Subsets | 1 | 2007 | 313 | 0.270 |
Why?
|
| Cell Lineage | 12 | 2021 | 2574 | 0.270 |
Why?
|
| Response Elements | 2 | 2018 | 308 | 0.260 |
Why?
|
| Protein Kinases | 3 | 2009 | 1609 | 0.260 |
Why?
|
| Leukemia, B-Cell | 3 | 2002 | 86 | 0.260 |
Why?
|
| Enzyme Activation | 6 | 2012 | 3587 | 0.260 |
Why?
|
| Cryoprotective Agents | 2 | 2004 | 128 | 0.260 |
Why?
|
| Neoplasm Metastasis | 3 | 2017 | 4921 | 0.250 |
Why?
|
| Sperm Motility | 2 | 2004 | 266 | 0.250 |
Why?
|
| Fanconi Anemia | 2 | 2009 | 327 | 0.250 |
Why?
|
| Flow Cytometry | 10 | 2014 | 5900 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 1169 | 0.250 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 1131 | 0.250 |
Why?
|
| DNA, Neoplasm | 7 | 2017 | 1748 | 0.250 |
Why?
|
| Neoplasm Invasiveness | 3 | 2021 | 3633 | 0.250 |
Why?
|
| Lymphoma | 3 | 2016 | 1907 | 0.250 |
Why?
|
| Gene Rearrangement | 4 | 2007 | 1139 | 0.250 |
Why?
|
| Jurkat Cells | 4 | 2017 | 738 | 0.240 |
Why?
|
| Acetamides | 2 | 2004 | 260 | 0.240 |
Why?
|
| Metalloproteins | 4 | 2010 | 98 | 0.240 |
Why?
|
| Phosphorylation | 10 | 2020 | 8326 | 0.240 |
Why?
|
| Neuroectodermal Tumors | 1 | 2004 | 23 | 0.240 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 395 | 0.240 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 937 | 0.240 |
Why?
|
| Precursor Cells, B-Lymphoid | 3 | 2017 | 99 | 0.240 |
Why?
|
| Child | 36 | 2024 | 80891 | 0.240 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2006 | 190 | 0.240 |
Why?
|
| Adamantane | 1 | 2005 | 148 | 0.240 |
Why?
|
| Luminescent Proteins | 5 | 2017 | 839 | 0.240 |
Why?
|
| Thymus Gland | 5 | 2013 | 1266 | 0.240 |
Why?
|
| Species Specificity | 6 | 2014 | 2417 | 0.230 |
Why?
|
| G1 Phase | 3 | 2020 | 403 | 0.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2019 | 2911 | 0.230 |
Why?
|
| Phosphoproteins | 2 | 2011 | 2448 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 5 | 2020 | 5443 | 0.230 |
Why?
|
| Genes, Dominant | 1 | 2007 | 856 | 0.230 |
Why?
|
| Stress, Physiological | 1 | 2011 | 1410 | 0.220 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2017 | 855 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 4 | 2021 | 6132 | 0.220 |
Why?
|
| Mutation, Missense | 3 | 2011 | 2593 | 0.210 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 656 | 0.210 |
Why?
|
| Genes, Homeobox | 2 | 2002 | 289 | 0.210 |
Why?
|
| Genotype | 6 | 2023 | 13042 | 0.210 |
Why?
|
| Leukemia, Experimental | 3 | 2016 | 225 | 0.210 |
Why?
|
| Hematologic Neoplasms | 3 | 2014 | 1905 | 0.210 |
Why?
|
| RNA Interference | 6 | 2021 | 2836 | 0.210 |
Why?
|
| Spermatozoa | 2 | 2004 | 631 | 0.200 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2002 | 49 | 0.200 |
Why?
|
| Integrases | 1 | 2005 | 520 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2022 | 362 | 0.200 |
Why?
|
| Hematologic Diseases | 2 | 2003 | 499 | 0.200 |
Why?
|
| Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2022 | 11 | 0.200 |
Why?
|
| Spinal Cord | 1 | 2010 | 1813 | 0.200 |
Why?
|
| Aspartate-Ammonia Ligase | 1 | 2022 | 18 | 0.200 |
Why?
|
| Anemia, Diamond-Blackfan | 2 | 2014 | 147 | 0.200 |
Why?
|
| Child, Preschool | 24 | 2020 | 42650 | 0.200 |
Why?
|
| Cell Separation | 4 | 2011 | 1726 | 0.200 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2020 | 608 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 4 | 2021 | 4414 | 0.200 |
Why?
|
| Acyltransferases | 2 | 2021 | 306 | 0.200 |
Why?
|
| Genome | 2 | 2009 | 1747 | 0.200 |
Why?
|
| Ploidies | 4 | 2008 | 287 | 0.190 |
Why?
|
| Hyperplasia | 2 | 2017 | 1153 | 0.190 |
Why?
|
| Leukopoiesis | 1 | 2001 | 54 | 0.190 |
Why?
|
| Leucine Zippers | 1 | 2001 | 116 | 0.190 |
Why?
|
| Radiation Tolerance | 4 | 2012 | 478 | 0.190 |
Why?
|
| In Situ Hybridization, Fluorescence | 7 | 2012 | 2524 | 0.190 |
Why?
|
| Drug Discovery | 3 | 2015 | 1067 | 0.180 |
Why?
|
| Models, Biological | 9 | 2017 | 9493 | 0.180 |
Why?
|
| Binding Sites | 4 | 2017 | 6017 | 0.180 |
Why?
|
| Protein Structure, Tertiary | 6 | 2009 | 3779 | 0.180 |
Why?
|
| Asparaginase | 1 | 2022 | 240 | 0.170 |
Why?
|
| Enzyme Activators | 1 | 2020 | 56 | 0.170 |
Why?
|
| Topotecan | 1 | 2020 | 131 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2004 | 725 | 0.170 |
Why?
|
| Immunohistochemistry | 8 | 2012 | 11120 | 0.170 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2021 | 564 | 0.170 |
Why?
|
| Deoxycytidine Kinase | 1 | 2019 | 11 | 0.170 |
Why?
|
| ras Proteins | 4 | 2014 | 1058 | 0.170 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2019 | 17 | 0.170 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 1671 | 0.170 |
Why?
|
| Sympathetic Nervous System | 3 | 2010 | 521 | 0.170 |
Why?
|
| Arabinonucleosides | 1 | 2019 | 34 | 0.170 |
Why?
|
| RNA, Messenger | 15 | 2012 | 12805 | 0.170 |
Why?
|
| Organogenesis | 2 | 2019 | 214 | 0.160 |
Why?
|
| Genes, Neoplasm | 2 | 2012 | 370 | 0.160 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 11918 | 0.160 |
Why?
|
| Acetylation | 3 | 2022 | 1053 | 0.160 |
Why?
|
| Peroxidase | 2 | 2006 | 609 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 1608 | 0.160 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2010 | 308 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 501 | 0.160 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2020 | 252 | 0.160 |
Why?
|
| Remission Induction | 3 | 2023 | 2407 | 0.160 |
Why?
|
| Medical Oncology | 1 | 2011 | 2349 | 0.160 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 3434 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 1623 | 0.150 |
Why?
|
| Pyridines | 2 | 2012 | 2889 | 0.150 |
Why?
|
| Conserved Sequence | 3 | 2007 | 1163 | 0.150 |
Why?
|
| Phenotype | 10 | 2020 | 16721 | 0.150 |
Why?
|
| Chromosome Disorders | 2 | 2000 | 499 | 0.150 |
Why?
|
| Doxorubicin | 3 | 2022 | 2229 | 0.150 |
Why?
|
| Infant | 20 | 2018 | 36510 | 0.150 |
Why?
|
| Globins | 1 | 2019 | 405 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2017 | 224 | 0.150 |
Why?
|
| B-Lymphocytes | 2 | 2017 | 4785 | 0.150 |
Why?
|
| Prognosis | 14 | 2022 | 30022 | 0.150 |
Why?
|
| Multigene Family | 4 | 2010 | 1082 | 0.150 |
Why?
|
| HMGB Proteins | 1 | 2017 | 45 | 0.150 |
Why?
|
| Disease-Free Survival | 7 | 2014 | 6856 | 0.150 |
Why?
|
| Survival Analysis | 6 | 2019 | 10117 | 0.140 |
Why?
|
| Genes, myb | 1 | 2017 | 18 | 0.140 |
Why?
|
| Fish Proteins | 1 | 2017 | 48 | 0.140 |
Why?
|
| Genetic Linkage | 2 | 2002 | 2342 | 0.140 |
Why?
|
| bcl-Associated Death Protein | 2 | 2015 | 102 | 0.140 |
Why?
|
| Mice, Knockout | 9 | 2020 | 14481 | 0.140 |
Why?
|
| Anemia, Macrocytic | 2 | 2014 | 53 | 0.140 |
Why?
|
| Nuclear Pore Complex Proteins | 2 | 2011 | 164 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 731 | 0.140 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2017 | 56 | 0.140 |
Why?
|
| DNA, Complementary | 7 | 2010 | 1992 | 0.140 |
Why?
|
| RNA, Untranslated | 1 | 2020 | 457 | 0.140 |
Why?
|
| Down-Regulation | 6 | 2018 | 2940 | 0.140 |
Why?
|
| Protein Subunits | 1 | 2020 | 943 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2009 | 640 | 0.130 |
Why?
|
| DNA Methylation | 4 | 2022 | 4421 | 0.130 |
Why?
|
| Histone Chaperones | 1 | 2016 | 82 | 0.130 |
Why?
|
| Dexamethasone | 3 | 2018 | 1965 | 0.130 |
Why?
|
| Abnormalities, Multiple | 1 | 2003 | 1424 | 0.130 |
Why?
|
| Morpholines | 1 | 2019 | 584 | 0.130 |
Why?
|
| Kidney | 5 | 2017 | 7064 | 0.130 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2020 | 1755 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2014 | 6541 | 0.130 |
Why?
|
| Small Molecule Libraries | 2 | 2012 | 742 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 808 | 0.130 |
Why?
|
| Female | 37 | 2021 | 397089 | 0.130 |
Why?
|
| Blast Crisis | 1 | 2016 | 102 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 2475 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 2237 | 0.130 |
Why?
|
| Genome, Human | 3 | 2017 | 4450 | 0.130 |
Why?
|
| Neoplasms | 8 | 2012 | 22385 | 0.130 |
Why?
|
| Stem Cells | 4 | 2014 | 3539 | 0.130 |
Why?
|
| Multiprotein Complexes | 2 | 2020 | 1110 | 0.130 |
Why?
|
| 5' Untranslated Regions | 1 | 2017 | 255 | 0.130 |
Why?
|
| Catalytic Domain | 2 | 2014 | 698 | 0.130 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
| Cyclin C | 1 | 2014 | 12 | 0.120 |
Why?
|
| Cell Line | 10 | 2013 | 15597 | 0.120 |
Why?
|
| Membrane Proteins | 5 | 2015 | 7880 | 0.120 |
Why?
|
| Cells, Cultured | 9 | 2014 | 19022 | 0.120 |
Why?
|
| Benzamides | 2 | 2019 | 1380 | 0.120 |
Why?
|
| Dimerization | 3 | 2006 | 886 | 0.120 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2008 | 612 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2008 | 2750 | 0.120 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2014 | 30 | 0.120 |
Why?
|
| Glucocorticoids | 3 | 2018 | 2168 | 0.120 |
Why?
|
| Janus Kinase 3 | 2 | 2013 | 77 | 0.120 |
Why?
|
| Cell Tracking | 1 | 2016 | 140 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2014 | 450 | 0.120 |
Why?
|
| Mitotic Index | 1 | 2014 | 162 | 0.120 |
Why?
|
| Leucine | 2 | 2014 | 548 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 393 | 0.120 |
Why?
|
| Evolution, Molecular | 3 | 2014 | 1893 | 0.120 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2014 | 84 | 0.110 |
Why?
|
| Rodentia | 1 | 2016 | 262 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2014 | 76 | 0.110 |
Why?
|
| Sirolimus | 1 | 2021 | 1542 | 0.110 |
Why?
|
| Male | 33 | 2020 | 364902 | 0.110 |
Why?
|
| Down Syndrome | 1 | 2002 | 915 | 0.110 |
Why?
|
| DNA Primers | 3 | 2011 | 2825 | 0.110 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 2 | 2010 | 57 | 0.110 |
Why?
|
| Carrier Proteins | 4 | 2017 | 4936 | 0.110 |
Why?
|
| Tumor Burden | 2 | 2017 | 1913 | 0.110 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2014 | 133 | 0.110 |
Why?
|
| Tyrphostins | 1 | 2013 | 63 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2017 | 715 | 0.110 |
Why?
|
| Genetic Markers | 5 | 2006 | 2604 | 0.110 |
Why?
|
| Larva | 2 | 2012 | 514 | 0.110 |
Why?
|
| Cell Nucleolus | 1 | 2013 | 156 | 0.100 |
Why?
|
| DNA Helicases | 2 | 2014 | 853 | 0.100 |
Why?
|
| Mice, Transgenic | 5 | 2014 | 9562 | 0.100 |
Why?
|
| Melanophores | 1 | 2012 | 16 | 0.100 |
Why?
|
| Cyclin D | 1 | 2012 | 72 | 0.100 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2012 | 33 | 0.100 |
Why?
|
| Histones | 3 | 2015 | 2592 | 0.100 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 89 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1232 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2020 | 2890 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2018 | 1165 | 0.100 |
Why?
|
| Genes, Reporter | 4 | 2017 | 1524 | 0.100 |
Why?
|
| Cyclic S-Oxides | 2 | 2009 | 25 | 0.100 |
Why?
|
| Organisms, Genetically Modified | 1 | 2012 | 63 | 0.100 |
Why?
|
| Acute Disease | 4 | 2008 | 7242 | 0.100 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2013 | 209 | 0.100 |
Why?
|
| Erythrokeratodermia Variabilis | 1 | 2011 | 1 | 0.100 |
Why?
|
| Brefeldin A | 1 | 2011 | 68 | 0.100 |
Why?
|
| Cryoultramicrotomy | 1 | 2011 | 16 | 0.100 |
Why?
|
| Morphogenesis | 2 | 2007 | 747 | 0.100 |
Why?
|
| Thapsigargin | 1 | 2011 | 102 | 0.100 |
Why?
|
| Thiadiazoles | 2 | 2009 | 63 | 0.100 |
Why?
|
| Genes, bcl-2 | 3 | 2008 | 119 | 0.100 |
Why?
|
| Schwann Cells | 1 | 2012 | 196 | 0.090 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2011 | 166 | 0.090 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2011 | 189 | 0.090 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2020 | 1167 | 0.090 |
Why?
|
| Crystallization | 1 | 2012 | 521 | 0.090 |
Why?
|
| Chromosomes, Mammalian | 2 | 2010 | 148 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 515 | 0.090 |
Why?
|
| Antigens, CD | 2 | 2010 | 4031 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2012 | 259 | 0.090 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2014 | 664 | 0.090 |
Why?
|
| Cell Death | 4 | 2012 | 1682 | 0.090 |
Why?
|
| Noonan Syndrome | 2 | 2010 | 122 | 0.090 |
Why?
|
| Survival Rate | 6 | 2021 | 12870 | 0.090 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 269 | 0.090 |
Why?
|
| Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 2010 | 15 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 710 | 0.090 |
Why?
|
| Luminescent Measurements | 1 | 2012 | 343 | 0.090 |
Why?
|
| Rhabdomyosarcoma | 2 | 2011 | 358 | 0.090 |
Why?
|
| Hematopoietic System | 1 | 2010 | 110 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2013 | 2568 | 0.090 |
Why?
|
| Recombination, Genetic | 2 | 2007 | 1526 | 0.090 |
Why?
|
| DNA Mutational Analysis | 3 | 2010 | 4120 | 0.090 |
Why?
|
| Cell Aggregation | 1 | 2010 | 238 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2010 | 97 | 0.090 |
Why?
|
| Ganglioneuroblastoma | 1 | 2009 | 10 | 0.090 |
Why?
|
| CpG Islands | 1 | 2014 | 1209 | 0.090 |
Why?
|
| Microinjections | 2 | 2008 | 323 | 0.080 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2004 | 494 | 0.080 |
Why?
|
| Homeostasis | 2 | 2012 | 3349 | 0.080 |
Why?
|
| Connexins | 1 | 2011 | 355 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1739 | 0.080 |
Why?
|
| Melanocytes | 2 | 2011 | 508 | 0.080 |
Why?
|
| Neoplasm Staging | 8 | 2018 | 11254 | 0.080 |
Why?
|
| GATA1 Transcription Factor | 3 | 2011 | 306 | 0.080 |
Why?
|
| Diploidy | 2 | 2008 | 134 | 0.080 |
Why?
|
| Models, Genetic | 3 | 2007 | 3442 | 0.080 |
Why?
|
| Mitosis | 1 | 2014 | 1190 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2010 | 1246 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 5 | 2013 | 22355 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2011 | 1682 | 0.080 |
Why?
|
| Thrombopoiesis | 1 | 2010 | 166 | 0.080 |
Why?
|
| HeLa Cells | 5 | 2014 | 3088 | 0.080 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 348 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2010 | 1056 | 0.080 |
Why?
|
| Introns | 2 | 2015 | 968 | 0.080 |
Why?
|
| Adolescent | 17 | 2020 | 89184 | 0.080 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2003 | 697 | 0.080 |
Why?
|
| Caspase 3 | 2 | 2008 | 731 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2009 | 411 | 0.080 |
Why?
|
| S Phase | 2 | 2009 | 424 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2008 | 4775 | 0.080 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2008 | 101 | 0.080 |
Why?
|
| Myelin Sheath | 1 | 2012 | 653 | 0.080 |
Why?
|
| Gene Dosage | 2 | 2010 | 1221 | 0.080 |
Why?
|
| SOS1 Protein | 1 | 2008 | 40 | 0.080 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2009 | 241 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2010 | 354 | 0.070 |
Why?
|
| Cell Nucleus | 3 | 2012 | 2886 | 0.070 |
Why?
|
| Treatment Failure | 2 | 2014 | 2663 | 0.070 |
Why?
|
| Genes, vpr | 1 | 2007 | 19 | 0.070 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2007 | 24 | 0.070 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2007 | 49 | 0.070 |
Why?
|
| Protease Inhibitors | 2 | 2009 | 752 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 19 | 4 | 2010 | 350 | 0.070 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2008 | 83 | 0.070 |
Why?
|
| Crystallography, X-Ray | 1 | 2012 | 1952 | 0.070 |
Why?
|
| Kinetics | 2 | 2012 | 6333 | 0.070 |
Why?
|
| Retinoblastoma Protein | 2 | 2009 | 673 | 0.070 |
Why?
|
| Pyridones | 1 | 2013 | 818 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 874 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2010 | 962 | 0.070 |
Why?
|
| Cell Size | 1 | 2009 | 626 | 0.070 |
Why?
|
| Interleukin-10 | 1 | 2013 | 1184 | 0.070 |
Why?
|
| GTPase-Activating Proteins | 1 | 2010 | 471 | 0.070 |
Why?
|
| Cloning, Molecular | 4 | 2017 | 4168 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 2 | 2024 | 875 | 0.070 |
Why?
|
| Chromosome Mapping | 7 | 2009 | 4622 | 0.070 |
Why?
|
| Arsenicals | 1 | 2007 | 117 | 0.070 |
Why?
|
| Receptors, Cell Surface | 3 | 2005 | 2819 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2021 | 466 | 0.070 |
Why?
|
| Disease Progression | 5 | 2016 | 13646 | 0.070 |
Why?
|
| Genome-Wide Association Study | 4 | 2015 | 12778 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3827 | 0.070 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2005 | 308 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2011 | 968 | 0.070 |
Why?
|
| Ceramides | 1 | 2008 | 203 | 0.070 |
Why?
|
| Leukocytes | 3 | 2009 | 2030 | 0.070 |
Why?
|
| Pyrroles | 1 | 2013 | 1126 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 440 | 0.070 |
Why?
|
| Transfection | 3 | 2014 | 5764 | 0.070 |
Why?
|
| Spleen | 2 | 2003 | 2296 | 0.070 |
Why?
|
| U937 Cells | 1 | 2006 | 260 | 0.070 |
Why?
|
| Cell Line, Transformed | 2 | 2005 | 867 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1833 | 0.070 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 2 | 2005 | 195 | 0.070 |
Why?
|
| Chromosomal Instability | 1 | 2007 | 178 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 1305 | 0.070 |
Why?
|
| HL-60 Cells | 1 | 2006 | 364 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 1855 | 0.060 |
Why?
|
| Cyclin B1 | 1 | 2005 | 57 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2010 | 24318 | 0.060 |
Why?
|
| Muscular Atrophy | 1 | 2009 | 335 | 0.060 |
Why?
|
| Cyclin B | 1 | 2005 | 104 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2003 | 3663 | 0.060 |
Why?
|
| Cell Adhesion | 2 | 2014 | 3102 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2009 | 742 | 0.060 |
Why?
|
| Expressed Sequence Tags | 2 | 2004 | 250 | 0.060 |
Why?
|
| Oxides | 1 | 2007 | 403 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 2414 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2009 | 461 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2010 | 1502 | 0.060 |
Why?
|
| Whole-Body Irradiation | 2 | 2004 | 435 | 0.060 |
Why?
|
| Leukemia, Lymphoid | 1 | 2005 | 311 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 444 | 0.060 |
Why?
|
| Bone Marrow Examination | 1 | 2005 | 154 | 0.060 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2005 | 56 | 0.060 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2004 | 21 | 0.060 |
Why?
|
| Wounds and Injuries | 2 | 2009 | 2514 | 0.060 |
Why?
|
| K562 Cells | 1 | 2006 | 644 | 0.060 |
Why?
|
| Molecular Biology | 2 | 2005 | 573 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2020 | 6606 | 0.060 |
Why?
|
| Endopeptidases | 2 | 2005 | 765 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 720 | 0.060 |
Why?
|
| Genes, abl | 1 | 2004 | 69 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 703 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 1078 | 0.060 |
Why?
|
| Clone Cells | 2 | 2010 | 1671 | 0.060 |
Why?
|
| Piperidines | 1 | 2013 | 1659 | 0.060 |
Why?
|
| Sperm Capacitation | 1 | 2004 | 21 | 0.060 |
Why?
|
| Tretinoin | 1 | 2007 | 525 | 0.060 |
Why?
|
| Erythroid Precursor Cells | 1 | 2005 | 212 | 0.060 |
Why?
|
| Receptors, Cytokine | 1 | 2005 | 258 | 0.060 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 3 | 2001 | 355 | 0.060 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2008 | 555 | 0.060 |
Why?
|
| Bone Marrow | 2 | 2005 | 2929 | 0.060 |
Why?
|
| Annexin A2 | 1 | 2003 | 43 | 0.060 |
Why?
|
| Neutrophil Infiltration | 1 | 2006 | 395 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2006 | 482 | 0.060 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 15455 | 0.060 |
Why?
|
| Arteries | 1 | 2009 | 1126 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2008 | 683 | 0.060 |
Why?
|
| Chondrocytes | 1 | 2009 | 800 | 0.050 |
Why?
|
| Neutrophils | 3 | 2007 | 3785 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2006 | 600 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2003 | 137 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2005 | 1339 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2010 | 864 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2024 | 189 | 0.050 |
Why?
|
| Regeneration | 1 | 2012 | 1525 | 0.050 |
Why?
|
| Interleukin-7 | 1 | 2003 | 145 | 0.050 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2003 | 148 | 0.050 |
Why?
|
| Leukemic Infiltration | 1 | 2003 | 47 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2021 | 4291 | 0.050 |
Why?
|
| Nevus | 1 | 2005 | 205 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2742 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 6406 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2024 | 253 | 0.050 |
Why?
|
| Age Factors | 3 | 2014 | 18471 | 0.050 |
Why?
|
| Learning | 1 | 2012 | 1761 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2021 | 65379 | 0.050 |
Why?
|
| Lymphoid Tissue | 1 | 2004 | 446 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2010 | 419 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 9198 | 0.050 |
Why?
|
| Autophagy | 1 | 2010 | 1351 | 0.050 |
Why?
|
| Phylogeny | 3 | 2009 | 2843 | 0.050 |
Why?
|
| Vertebrates | 1 | 2003 | 227 | 0.050 |
Why?
|
| Motor Activity | 1 | 2012 | 2720 | 0.050 |
Why?
|
| Adult | 13 | 2024 | 223640 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2007 | 775 | 0.050 |
Why?
|
| Carbazoles | 2 | 2017 | 221 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2002 | 229 | 0.050 |
Why?
|
| Cytoprotection | 1 | 2002 | 200 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2002 | 183 | 0.050 |
Why?
|
| Asparagine | 1 | 2022 | 120 | 0.050 |
Why?
|
| Smegmamorpha | 1 | 2021 | 14 | 0.050 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2001 | 37 | 0.050 |
Why?
|
| Olfactory Bulb | 1 | 2003 | 198 | 0.050 |
Why?
|
| Cell Membrane Permeability | 1 | 2003 | 574 | 0.050 |
Why?
|
| beta Catenin | 1 | 2007 | 1047 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2012 | 2021 | 0.050 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2021 | 21 | 0.050 |
Why?
|
| RNA Probes | 1 | 2001 | 111 | 0.050 |
Why?
|
| Tricarboxylic Acids | 1 | 2021 | 26 | 0.050 |
Why?
|
| Polyglutamic Acid | 1 | 2001 | 47 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 1885 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2002 | 402 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2022 | 125 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2001 | 199 | 0.050 |
Why?
|
| Immunoblotting | 3 | 2012 | 1647 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2020 | 1884 | 0.050 |
Why?
|
| Co-Repressor Proteins | 1 | 2001 | 190 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2002 | 324 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 835 | 0.040 |
Why?
|
| Interleukin-15 | 1 | 2021 | 185 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 692 | 0.040 |
Why?
|
| Temperature | 1 | 2007 | 2235 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2009 | 1161 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 2206 | 0.040 |
Why?
|
| Heterozygote | 1 | 2007 | 2791 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 306 | 0.040 |
Why?
|
| Calcinosis | 1 | 2009 | 1481 | 0.040 |
Why?
|
| Laminin | 1 | 2021 | 406 | 0.040 |
Why?
|
| DNA Repair | 1 | 2009 | 2048 | 0.040 |
Why?
|
| Time Factors | 5 | 2014 | 40272 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2862 | 0.040 |
Why?
|
| Drug Design | 1 | 2004 | 1046 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 2004 | 2299 | 0.040 |
Why?
|
| Granulocytes | 1 | 2001 | 550 | 0.040 |
Why?
|
| Plasmids | 1 | 2004 | 2268 | 0.040 |
Why?
|
| Intestines | 1 | 2008 | 1912 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 1926 | 0.040 |
Why?
|
| Nervous System | 1 | 2002 | 547 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1999 | 363 | 0.040 |
Why?
|
| Fertility | 1 | 2003 | 772 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 1997 | 323 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 2394 | 0.040 |
Why?
|
| Neurons | 4 | 2012 | 9513 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 1350 | 0.040 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2005 | 1376 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2021 | 807 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 6234 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2019 | 228 | 0.040 |
Why?
|
| Interleukin-3 | 3 | 2005 | 425 | 0.040 |
Why?
|
| src Homology Domains | 1 | 1998 | 362 | 0.040 |
Why?
|
| Proteomics | 3 | 2020 | 3906 | 0.040 |
Why?
|
| Homozygote | 1 | 2002 | 1779 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 2709 | 0.040 |
Why?
|
| Genes, DCC | 1 | 1997 | 10 | 0.040 |
Why?
|
| Open Reading Frames | 3 | 2010 | 812 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 2002 | 1616 | 0.040 |
Why?
|
| Cytogenetic Analysis | 2 | 2010 | 270 | 0.040 |
Why?
|
| Proteins | 4 | 2012 | 6006 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2001 | 2176 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2012 | 566 | 0.030 |
Why?
|
| Organ Specificity | 3 | 2015 | 1967 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2012 | 692 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 1602 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 3055 | 0.030 |
Why?
|
| Etoposide | 2 | 2010 | 639 | 0.030 |
Why?
|
| Genes, ras | 2 | 2011 | 665 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 1493 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2002 | 1532 | 0.030 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2017 | 289 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 10377 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2001 | 1135 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 615 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1997 | 373 | 0.030 |
Why?
|
| Mitochondria | 2 | 2008 | 3675 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1999 | 564 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2009 | 317 | 0.030 |
Why?
|
| Allelic Imbalance | 1 | 2015 | 77 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 3 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Carboplatin | 2 | 2010 | 799 | 0.030 |
Why?
|
| X Chromosome | 1 | 1998 | 819 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2021 | 2079 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2005 | 2058 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2015 | 163 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1998 | 529 | 0.030 |
Why?
|
| Caenorhabditis elegans | 2 | 2001 | 1467 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1996 | 431 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2014 | 49 | 0.030 |
Why?
|
| Fertilization in Vitro | 1 | 2003 | 1302 | 0.030 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 1994 | 94 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2021 | 1894 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2017 | 648 | 0.030 |
Why?
|
| Risk Factors | 6 | 2017 | 74962 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 3712 | 0.030 |
Why?
|
| Methotrexate | 1 | 2001 | 1722 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 354 | 0.030 |
Why?
|
| Immunophenotyping | 2 | 2013 | 1866 | 0.030 |
Why?
|
| Genes, Switch | 1 | 2014 | 48 | 0.030 |
Why?
|
| Perphenazine | 1 | 2014 | 33 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 5336 | 0.030 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2014 | 164 | 0.030 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 116 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 8051 | 0.030 |
Why?
|
| Immunoconjugates | 1 | 2021 | 969 | 0.030 |
Why?
|
| Epithelium | 2 | 2009 | 1609 | 0.030 |
Why?
|
| Risk | 2 | 2021 | 9636 | 0.030 |
Why?
|
| Inflammation | 3 | 2009 | 10863 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 126 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 1993 | 93 | 0.030 |
Why?
|
| Pigmentation | 1 | 2014 | 143 | 0.030 |
Why?
|
| Quinolones | 1 | 2016 | 382 | 0.030 |
Why?
|
| Macrophages | 1 | 2008 | 5796 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 379 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2001 | 2611 | 0.030 |
Why?
|
| CRADD Signaling Adaptor Protein | 1 | 2012 | 6 | 0.030 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2009 | 160 | 0.030 |
Why?
|
| Collagen | 1 | 2021 | 2646 | 0.030 |
Why?
|
| Dopamine Antagonists | 1 | 2014 | 289 | 0.030 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2013 | 136 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 525 | 0.030 |
Why?
|
| Computational Biology | 2 | 2018 | 3543 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2005 | 22296 | 0.030 |
Why?
|
| Cyclophosphamide | 2 | 2010 | 2226 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2001 | 1723 | 0.020 |
Why?
|
| 5'-Nucleotidase | 1 | 1993 | 164 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 293 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1993 | 283 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3632 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 59686 | 0.020 |
Why?
|
| Leukemia, Radiation-Induced | 1 | 2011 | 39 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2002 | 2476 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 20224 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2004 | 3078 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2012 | 252 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2397 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 1319 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2016 | 864 | 0.020 |
Why?
|
| Cisplatin | 2 | 2009 | 1661 | 0.020 |
Why?
|
| GATA2 Transcription Factor | 1 | 2011 | 158 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1993 | 896 | 0.020 |
Why?
|
| Lysine | 1 | 2015 | 988 | 0.020 |
Why?
|
| Piperazines | 2 | 2016 | 2552 | 0.020 |
Why?
|
| LEOPARD Syndrome | 1 | 2010 | 12 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10776 | 0.020 |
Why?
|
| Neprilysin | 1 | 1993 | 487 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2016 | 863 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1705 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 11221 | 0.020 |
Why?
|
| Gastrula | 1 | 2010 | 83 | 0.020 |
Why?
|
| Neural Tube | 1 | 2010 | 48 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14737 | 0.020 |
Why?
|
| Insulin | 1 | 2004 | 6607 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2012 | 625 | 0.020 |
Why?
|
| Epigenomics | 1 | 2015 | 959 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2012 | 506 | 0.020 |
Why?
|
| Cell Division | 2 | 2010 | 4479 | 0.020 |
Why?
|
| Cadherins | 1 | 2014 | 906 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2015 | 936 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 6510 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2009 | 12 | 0.020 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 1992 | 249 | 0.020 |
Why?
|
| Desmosomes | 1 | 2009 | 73 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2014 | 571 | 0.020 |
Why?
|
| Oxygen | 1 | 2021 | 4273 | 0.020 |
Why?
|
| beta Karyopherins | 1 | 2009 | 46 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2010 | 417 | 0.020 |
Why?
|
| Hematinics | 1 | 2012 | 282 | 0.020 |
Why?
|
| Research Report | 1 | 2012 | 369 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2009 | 125 | 0.020 |
Why?
|
| Transport Vesicles | 1 | 2009 | 81 | 0.020 |
Why?
|
| Rats | 2 | 2020 | 23835 | 0.020 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2008 | 43 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2009 | 199 | 0.020 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2009 | 148 | 0.020 |
Why?
|
| Aged | 4 | 2016 | 171562 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2009 | 286 | 0.020 |
Why?
|
| Chromatin | 1 | 2020 | 2968 | 0.020 |
Why?
|
| Quinolines | 1 | 2014 | 768 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2009 | 146 | 0.020 |
Why?
|
| Cell Dedifferentiation | 1 | 2009 | 124 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3438 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2010 | 881 | 0.020 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2008 | 44 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2011 | 841 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 2636 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2008 | 81 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 2003 | 816 | 0.020 |
Why?
|
| Nitrobenzenes | 1 | 2007 | 66 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2000 | 2537 | 0.020 |
Why?
|
| Imidazoles | 1 | 2014 | 1168 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2008 | 317 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2009 | 361 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 77 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2000 | 4049 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 15939 | 0.020 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2007 | 32 | 0.020 |
Why?
|
| Diffusion | 1 | 2009 | 818 | 0.020 |
Why?
|
| Lentivirus | 1 | 2010 | 519 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2009 | 344 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2007 | 216 | 0.020 |
Why?
|
| Caspases | 1 | 2009 | 881 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 2201 | 0.020 |
Why?
|
| DNA | 3 | 2011 | 7211 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5496 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2006 | 241 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 489 | 0.020 |
Why?
|
| Mesoderm | 1 | 2009 | 679 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 12558 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1881 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2004 | 5713 | 0.020 |
Why?
|
| Pheochromocytoma | 1 | 2008 | 328 | 0.020 |
Why?
|
| Pediatrics | 1 | 2021 | 3624 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 1755 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 2002 | 0.020 |
Why?
|
| Ifosfamide | 1 | 2005 | 234 | 0.020 |
Why?
|
| Monocytes | 1 | 1994 | 2595 | 0.020 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2005 | 22 | 0.020 |
Why?
|
| Artificial Gene Fusion | 1 | 2004 | 56 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2009 | 724 | 0.010 |
Why?
|
| Peptides | 1 | 2016 | 4353 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2005 | 152 | 0.010 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2005 | 93 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1748 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2014 | 2421 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2830 | 0.010 |
Why?
|
| Young Adult | 3 | 2017 | 60049 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2005 | 287 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 1371 | 0.010 |
Why?
|
| Middle Aged | 3 | 2009 | 223491 | 0.010 |
Why?
|
| Serine | 1 | 2008 | 831 | 0.010 |
Why?
|
| Neoplasms, Second Primary | 1 | 1992 | 1060 | 0.010 |
Why?
|
| Feedback, Physiological | 1 | 2006 | 481 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 2005 | 287 | 0.010 |
Why?
|
| Ganglia, Sympathetic | 1 | 2004 | 65 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3107 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 303 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2009 | 1337 | 0.010 |
Why?
|
| Smoking | 1 | 2000 | 9111 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2009 | 1530 | 0.010 |
Why?
|
| Protein Transport | 1 | 2009 | 1958 | 0.010 |
Why?
|
| Mosaicism | 1 | 2007 | 481 | 0.010 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2008 | 798 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2023 | 54920 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2010 | 1361 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 2005 | 337 | 0.010 |
Why?
|
| Transplantation | 1 | 2005 | 221 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2013 | 5404 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2006 | 549 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 39407 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 2004 | 385 | 0.010 |
Why?
|
| Peripheral Nervous System | 1 | 2004 | 151 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2004 | 370 | 0.010 |
Why?
|
| Medulloblastoma | 1 | 2008 | 682 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2004 | 393 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2004 | 534 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2005 | 753 | 0.010 |
Why?
|
| Biopsy | 1 | 2014 | 6808 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2008 | 2695 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 1026 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 474 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2005 | 560 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 478 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2008 | 911 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 902 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2012 | 2588 | 0.010 |
Why?
|
| Gene Library | 1 | 2004 | 1061 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2559 | 0.010 |
Why?
|
| Cytokines | 2 | 2009 | 7445 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2008 | 1277 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8506 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 808 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2004 | 900 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12092 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 1742 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2010 | 2630 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2008 | 1346 | 0.010 |
Why?
|
| Paternal Behavior | 1 | 2000 | 33 | 0.010 |
Why?
|
| Neutropenia | 1 | 2005 | 893 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 1901 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2005 | 1207 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2005 | 736 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6210 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2003 | 1157 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1999 | 6971 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 2005 | 945 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2004 | 1078 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2001 | 434 | 0.010 |
Why?
|
| Maternal Behavior | 1 | 2000 | 309 | 0.010 |
Why?
|
| Wound Healing | 1 | 2009 | 2813 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2276 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2004 | 1600 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6241 | 0.010 |
Why?
|
| Myosin Light Chains | 1 | 1997 | 122 | 0.010 |
Why?
|
| COS Cells | 1 | 1999 | 1135 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2005 | 2489 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2005 | 1428 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1997 | 1553 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 9261 | 0.010 |
Why?
|
| Core Binding Factors | 1 | 1994 | 29 | 0.010 |
Why?
|
| Chickens | 1 | 1997 | 845 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 1994 | 79 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2005 | 1643 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 4981 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 1997 | 841 | 0.010 |
Why?
|
| Muscles | 1 | 1997 | 1582 | 0.010 |
Why?
|
| Aging | 1 | 2010 | 8764 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2005 | 2923 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 41795 | 0.010 |
Why?
|
| Chimera | 1 | 1991 | 454 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2094 | 0.000 |
Why?
|
| Algorithms | 1 | 2009 | 14154 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 2008 | 81801 | 0.000 |
Why?
|
| Exons | 1 | 1992 | 2392 | 0.000 |
Why?
|
| Logistic Models | 1 | 2000 | 13323 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2000 | 26411 | 0.000 |
Why?
|
| United States | 1 | 2008 | 73150 | 0.000 |
Why?
|
| Pregnancy | 1 | 2000 | 30200 | 0.000 |
Why?
|